SCHEMBL4975764

SCHEMBL4975764

O=C(NC1CC1)c1ccc(-c2ccccc2)c(CCN(c2cccnc2)c2cccnc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP46A1 Q9Y6A2 1/20 0.53
ALDH1A1 P00352 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
PTAFR P25105 2/20 0.45
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
RIPK2 O43353 3/20 0.43
DRD4 P21917 1/20 0.43
MAPK14 Q16539 3/20 0.42
MAPK13 O15264 1/20 0.42
MAPK12 P53778 1/20 0.42
MAPK11 Q15759 1/20 0.42
PDK1 Q15118 1/20 0.41
SMYD3 Q9H7B4 3/20 0.41
LCK P06239 1/20 0.41
CSF1R P07333 1/20 0.41
KDR P35968 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4975675 0.86 MKNK1 (0.47) PTAFRNPC1RAB9APDK1ROCK2
SCHEMBL4982009 0.83 MKNK1 (0.47) PTAFR
SCHEMBL4977669 0.81 CYP11B1 (0.54) ALDH1A1PTAFRMEN1KMT2APDK1
SCHEMBL1368662 0.77 CYP46A1 (0.53) CYP46A1ALDH1A1L3MBTL1PTAFRMEN1
SCHEMBL4977077 0.77 CYP11B1 (0.53) ALDH1A1PTAFRMEN1NPC1RAB9A
SCHEMBL4980305 0.74 KCNA5 (0.39) NPC1RAB9A
SCHEMBL4979253 0.74 CYP11B2 (0.46)
SCHEMBL4975773 0.74 KCNA5 (0.39) ALDH1A1MEN1NPC1RAB9AKMT2A
SCHEMBL4977530 0.72 CYP11B1 (0.48)
SCHEMBL4979558 0.72 CYP11B2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1993551-A2 POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2008-11-26 EP disclosed
WO-2007089735-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2007-08-09 WO disclosed